News & Events

Partners in industry and research are aiming to optimise the diagnosis of cancer and other diseases with a novel microscopy technique. The QEED research project has been allocated a two-figure million sum in funding. ECRC scientist Hendrik Bartolomaeus is a member of the consortium.

At the “Hauptstadtforum” of the MINT-EC school excellence network, students had the opportunity to learn about the latest research at the Max Delbrück Center, including how to use machine learning to decode data and enhance immune cells to protect from COVID-19.

Employees of the Max Delbrück Center and the Experimental and Clinical Research Center are mourning the loss of Gisela Krebs, who has passed away at the age of 91. Since 2015, her foundation has been supporting muscle desease research.

The pianist SooJin Anjou and the scientist Nikolaus Rajewsky are both experts in their respective fields. Together, they have created the event series “Spark”: a concert and meet-up for creative people, an exploration to learn from both sides. On March 13th, the series continued at MDC-BIMSB.

Reflections on equity in science: How can the progress that has been made teach us to overcome the challenges that remain? Professor Maike Sander, Scientific Director of the Max Delbrück Center, and Raeka Aiyar, PhD, Vice President, Scientific & DEIB Outreach of the NYSCF Research Institute chatted about how far we’ve come and the road ahead.

Michael Potente wants to find out what makes blood vessels grow. For his work on the metabolic regulation of such growth, he has been selected as the recipient of the 2023 Judah Folkman Award from the North American Vascular Biology Organization.

Dr. Eleonora Adami is a postdoctoral research fellow at the Max Delbrück Center. The molecular biologist and geneticist studies heart failure by applying single-cell genomics approaches in the Hübner lab.

Michael Bader has received over half a million euros from the LEO Foundation. The funding will help him develop a therapy for vitiligo and other inflammatory skin conditions. He hopes the answer lies in an ointment that inhibits ACE2, an enzyme that gained global attention during the coronavirus pandemic.

This woman knows what a good book is. Petra Nibbe used to be a bookseller before she moved into the world of business law and human resources management. Nibbe, who is now head of the People and Culture Department at the Max Delbrück Center, takes us to Georgia, to the era after the collapse of the Soviet Union.